Galangin attenuates mast cell-mediated allergic inflammation

Area of Science:

• Immunology
• Pharmacology
• Natural Product Chemistry

Background:

• Allergic inflammatory diseases like asthma and dermatitis affect many people.
• Discovering effective treatments for these conditions is crucial for public health.

Purpose of the Study:

• To investigate the anti-allergic inflammatory effects of galangin.
• To elucidate the mechanisms underlying galangin's action in allergic reactions.

Main Methods:

• In vitro studies using human mast cells (HMC-1) stimulated with phorbol 12-mystate 13-acetate and calcium ionophore A23187.
• In vivo assessment using IgE-mediated passive cutaneous anaphylaxis model.
• Analysis of intracellular calcium levels, pro-inflammatory cytokine expression (TNF-α, IL-6, IL-1β, IL-8), and signaling pathways (JNK, p38 MAPK, NF-κB, caspase-1).

Main Results:

• Galangin significantly inhibited histamine release by reducing intracellular calcium in HMC-1 cells.
• Galangin decreased the expression of key pro-inflammatory cytokines and related signaling molecules.
• In vivo, galangin attenuated allergic reactions and histamine receptor 1 expression, showing greater potency than cromolyn.

Conclusions:

• Galangin effectively down-regulates mast cell-mediated allergic inflammatory responses.
• Its mechanisms involve blocking histamine release and suppressing pro-inflammatory cytokine production.
• Galangin demonstrates potential as a beneficial therapeutic agent for allergic inflammatory diseases.